New Research Unlocks Secrets of Brain Receptors, Paving Way for Novel Neurological Treatments
Two new studies from Weill Cornell Medicine reveal the complex ways metabotropic glutamate receptors (mGluRs) interact with regulatory proteins. This breakthrough offers a deeper understanding of these crucial drug targets, potentially leading to more effective treatments for epilepsy, depression, and anxiety disorders.